Health TrialsbyHealthPanel

Gingival Recessions in Orthodontically Treated and Untreated Adult Patients

ConditionsGingival RecessionOrthodontic Treatment
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

To identify the predisposing parameters for gingival recessions in adult patients seeking orthodontic treatment. The ultimate aim is to provide a clinical guideline to estimate the risk of developing post-orthodontic gingival recessions.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with or without previous history of orthodontic treatment with and without gingival recessions

≥ 18 years old

American Society of Anesthesiologists Classification I or II

Disqualifiers

Patients with history of periodontal disease

taking the following medication: anticoagulants, phenytoin, cyclosporine, nifedipine or calcium channel blockers

Patients with prior history of radio or chemotherapy

Pregnant or breastfeeding patients

Trial population

Patients adults with or without previous history of orthodontic treatment with and without gingival recessions

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Registration of parameters

    Other intervention

    De gingival and occlusal parameters will be recorded for the 4 different cohort groups

Treatment groups

50 Participants
are divided into 4 treatment groups
Group A: Orthodontically treated patient - with recession1 intervention
Group B: Orthodontically treated patient - without recession0 interventions
Group C: Orthodontically untreated patient - with recession1 intervention
Group D: Orthodontically untreated patient - without recession0 interventions

Trial outcomes

Primary outcomes

1

Gingival parameters

Presence of Recessions (Location and extension): in mm (0 to 9)

Time frame
6 months
2

Periodontal phenotype:

measured from 0.01 to 9.00 (Biometric Ultrasound Scanner)

Time frame
6 months
3

Full Mouth Bleeding scores (FMBS)

In % of total sites (0 to 100)

Time frame
6 months
4

Full Mouth Plaque Score (FMPS)

In % of total sites (0 to 100)

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universitaire Ziekenhuizen KU Leuven

Lead sponsor

Source ClinicalTrials.gov
Apply now